首页> 外文期刊>Kobe journal of medical sciences >A Case of Congenital Complete Atrioventricular Block Treated with Transdermal Tulobuterol
【24h】

A Case of Congenital Complete Atrioventricular Block Treated with Transdermal Tulobuterol

机译:透皮妥洛特罗治疗先天性完全性房室传导阻滞1例

获取原文
           

摘要

Congenital complete atrioventricular block (CCAVB) is a condition in which the atria and ventriclesbeat independently of each other. CCAVB cases require permanent pacemaker implantation untiladulthood. Nevertheless, consensus regarding postnatal medical therapy for bradycardia has not beenreached. Here we report the case of a newborn with CCAVB, whose intractable bradycardia wassuccessfully treated with transdermal tulobuterol. Tulobuterol is a selective ?2-adrenoceptor agonist,widely used safely as bronchodilator in children. It also has positive inotropic and chronotropic effect via?1-adrenoceptors. We believe the tulobuterol patch can be used as an optional therapy for CCAVB wherepacemaker implantation is not available.
机译:先天性完全房室传导阻滞(CCAVB)是心房和心室相互独立跳动的病状。 CCAVB病例需要永久性起搏器植入直至成年。然而,关于产后心动过缓的药物治疗尚未达成共识。在这里,我们报道了一名患有CCAVB的新生儿,其顽固性心动过缓已通过透皮妥洛特罗成功治疗。妥洛特罗是一种选择性的β2-肾上腺素受体激动剂,被广泛安全地用作儿童的支气管扩张剂。通过β1-肾上腺素受体也具有正性变力和变时性作用。我们认为,在无法起搏器植入的情况下,妥洛特罗贴片可作为CCAVB的可选疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号